Document:

Exhibit

EXHIBIT 10.24

SECOND AMENDMENT 
TO  
SENIOR UNSECURED REVOLVING CREDIT AGREEMENT

This SECOND AMENDMENT TO SENIOR UNSECURED REVOLVING CREDIT AGREEMENT (this “Amendment”) is made and entered into as of November 28, 2017, by and among WESTLAKE CHEMICAL PARTNERS LP, a Delaware limited partnership (“Borrower”), as borrower and WESTLAKE CHEMICAL FINANCE CORPORATION, a Delaware corporation (“Lender”), as lender.
W I T N E S S E T H
WHEREAS, the parties hereto entered into that certain Senior Unsecured Revolving Credit Agreement, dated as of April 29, 2015, as further amended on August 1, 2017 (the “Credit Agreement”), pursuant to which the Lender has made certain financial accommodations available to the Borrower;  and   
WHEREAS, the Lender desires to make certain modifications to the Credit Agreement to extend the maturity date thereof as more fully set forth herein;
NOW, THEREFORE, in consideration of the mutual covenants and the payment contained herein, and subject to the terms and conditions herein set forth, the parties hereby agree as follows:
SECTION 1.DEFINITIONS
1.1    Unless otherwise defined herein, including in the text of the preamble and recitals hereto, all capitalized terms used herein shall have the respective meanings given to such terms in Section 1.1 of the Credit Agreement, as amended hereby.  
1.2    The rules of interpretation set forth in Sections 1.2 and 1.3 of the Credit Agreement shall apply to this Amendment in all respects.
SECTION 2.    AMENDMENT
2.1    The defined term “Loan Commitment” is hereby deleted in its entirety and replaced with the following:
“‘Loan Commitment’ shall mean the obligation of the Lender to make Loans hereunder in an aggregate principal amount at any time outstanding not exceeding $600,000,000.”.
SECTION 3.    EFFECTIVENESS
3.1    This Amendment shall become effective upon the execution and delivery of this Amendment by the Borrower and the Lender.

SECTION 4.    MISCELLANEOUS
4.1    Full Force and Effect.  Except as specifically amended hereby, all of the terms and conditions of the Credit Agreement are unaffected and shall continue to be in full force and effect and shall be binding on the parties hereto in accordance with their respective terms.  Each reference to the Credit Agreement therein or in any other agreement, document or instrument executed and delivered pursuant to the Credit Agreement shall mean and constitute a reference to the Credit Agreement as amended hereby.  Except as specifically set forth in this Amendment, nothing in this Amendment shall be construed as modifying any other term or condition of the Credit Agreement or operate as a waiver of, or in prejudice to, any right, power or remedy of the Lender under the Credit Agreement, any applicable law or any existing or future Default or Event of Default.  
4.2    Headings.  Section headings used herein are for convenience of reference only, are not part of this Amendment and shall not affect the construction of, or be taken into consideration in interpreting, this Amendment.
4.3    Counterparts.  This Amendment may be executed in any number of counterparts, each of which shall be enforceable against the party executing such counterpart, and all of which together shall constitute one instrument.  Each counterpart may be delivered in original, facsimile or electronic (e.g., “.pdf”) form.
4.4    Governing Law.  This Amendment shall be construed in accordance with and governed by the law of the State of New York.
[The remainder of this page is intentionally left blank.]

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the day and year first above written.

	
			
	 
	WESTLAKE CHEMICAL PARTNERS LP
By: Westlake Chemical Partners GP LLC, its general partner
as Borrower

	 
	By:
	              /S/ M. STEVEN BENDER              

	 
	 
	Name: M. Steven Bender

	 
	

	Title: Senior Vice President and Chief Financial Officer

	 
	

WESTLAKE CHEMICAL FINANCE CORPORATION
as Lender

	 
	By:
	                  /S/   JEFF HOLY                        

	 
	 
	Name: Jeff Holy

	 
	

	Title: Vice President and TreasurerExhibit

Exhibit 10.4

RADIUS HEALTH, INC.
AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM
(Adopted on January 1, 2016*)

Set forth below is the Radius Health, Inc. (the “Company”) Non-Employee Director Compensation Program (this “Program”).  Capitalized terms not otherwise defined herein shall have the meaning ascribed thereto in the Company’s 2011 Equity Incentive Plan, as amended, or any other applicable Company equity incentive plan then-maintained by the Company (the “Plan”).

Cash Compensation
Annual retainers will be paid in the following amounts to Non-Employee Directors:

	
				
	Non-Employee Director:
	

	$50,000
	

	Chair of Audit Committee:
	

	$20,000
	

	Chair of Compensation Committee:
	

	$15,000
	

	Chair of Nominating and Corporate Governance Committee:
	

	$10,000
	

	Chair of Strategy Committee:
	

	$15,000
	

	Audit Committee Member (other than Chair):
	

	$10,000
	

	Compensation Committee Member (other than Chair):
	

	$7,500
	

	Nominating and Corporate Governance Committee Member (other than Chair):
	

	$5,000
	

	Strategy Committee Member (other than Chair):
	

	$7,500
	

	Independent Chairman:
	

	$25,000
	

All annual retainers will be paid in cash quarterly in arrears promptly following the end of the applicable calendar quarter, but in no event more than thirty (30) days after the end of such quarter.  In the event a Non-Employee Director does not serve as a Non-Employee Director or in one of the other positions identified above for an entire calendar quarter, the retainer paid to the Non-Employee director for the applicable calendar quarter will be prorated for the portion of the calendar quarter during which the applicable services were actually rendered.
Equity Compensation
	
		
	Initial Stock Option Grant:
	Each Non-Employee Director who is initially elected or appointed to serve on the Board after the date hereof shall be granted an Option to purchase 30,000 shares of Stock under the Plan (the “Initial Option”).
The Initial Option will automatically, and without further action by the Board or Committee, be granted on the date on which such Non-Employee Director commences service on the Board, and will vest in substantially equal installments on each of the first four anniversaries of the date of grant, subject to continued service as a Non-Employee Director through each vesting date.

	Annual Equity Grant:
	Each year, beginning in 2018, subject to any annual limits in the Plan on the maximum number of shares subject to an award to an individual Director, any Director who has been serving on the Board as a Non-Employee Director for at least 3 months as of the date of the grant of annual incentive equity awards for Executive Officers of the Company shall be granted (i) an Option to purchase 8,800 shares of Stock under the Plan and (ii) Restricted Stock Units representing the right to receive 4,800 shares of Stock under the Plan (the “Annual Award”).  
The Annual Award will automatically, and without further action by the Board or Committee, be granted on the date of the grant of annual incentive equity awards for Executive Officers of the Company, and will vest in full on the first (1st) anniversary of the date of grant, subject in each case to continued service through the vesting date.

Change of Control
Upon a Change of Control, all outstanding equity awards granted under the Plan or any other equity incentive plan maintained by the Company that are held by a Non-Employee Director shall become fully vested and/or exercisable, irrespective of any other provisions of the Non-Employee Director’s award agreement.
Miscellaneous
The provisions of the applicable Plan shall apply to the Awards granted pursuant to this Program, except to the extent such provisions are inconsistent with this Program.  All applicable terms of the Plan apply to this Program as if fully set forth herein.  The grant of any Option and Restricted Stock Unit under this Program shall be made solely by and subject to the terms set forth in a written agreement substantially in the form of the stock option agreement and restricted stock unit agreement approved by the Board and duly executed by an executive officer of the Company.  The exercise price per share of Stock subject to an Option granted under this Program shall be the Market Value of a share of Stock on the Option’s date of grant.
Amendment, Modification and Termination
This Program may be amended, modified or terminated by the Board at any time in its sole discretion.  No Non-Employee Director shall have any rights hereunder, except with respect to an Award granted pursuant to the Program.  

*Amended, effective as of February 13, 2018.Exhibit

Exhibit 10.15

950 Winter Street
Waltham, MA 02451
Tel: (617) 551-4000
Fax: (617) 551-4701

November 10, 2017

Dear Joseph,

I am pleased to offer you full-time employment with Radius Health, Inc. (“Radius” or the “Company”) as the Senior Vice President, Sales and Marketing of Radius reporting to Jesper Høiland, Chief Executive Officer of Radius. Your position will be based out of our Wayne, PA corporate offices with a start date of November 27, 2017.

In the course of your employment with Radius, you will be subject to and required to comply with all Company policies, and applicable laws and regulations. The Company requires that, as a full-time employee, you devote your full business time, attention, skill, and efforts to the tasks and duties of your position with the Company. The term “Agreement” as used below shall mean this letter agreement.

The starting salary for this position is $15,625.00 on a semi-monthly basis, which annualized is $375,000.00 (less applicable taxes and withholdings).  You will receive your first performance appraisal in January 2019. Your performance will be reviewed annually thereafter.  Salary increases will be based on the relationship of your salary to the market and your individual performance, and are provided at the sole discretion of Radius.

This Agreement is contingent upon, and will become effective only upon, (i) your successful completion of a drug screening test prior to your first day of employment; (ii) satisfactory results of a comprehensive background check (including, but not limited to, social security number, previous employment, conviction record, FDA/OIG/SAM debarment and education); and (iii) proof of your eligibility to work for Radius in the United States.

Bonus Eligibility
Commencing with the calendar year 2018, you will be eligible to participate in the Radius discretionary Bonus plan. Under this plan, your annual bonus incentive target will be 40% of your actual base earnings for the bonus plan year, and subject to approval by the Company’s Board of Directors (the “Board”), would be payable annually, generally in March of the plan year following the year to which the bonus pertains. Your actual incentive award will be based on your individual performance and the overall performance of Radius. The criteria and amount of the bonus will be determined on an annual basis, in Radius’ sole discretion.  You must be employed as of the pay-out date of any bonus in order to earn and be eligible to receive it.

Sign-On Bonus
You will be eligible to receive a Sign-On Bonus in the gross amount of $60,000.00 (less applicable taxes and withholdings). This bonus will be paid in the first pay period following completion of 90 days of employment. In the unlikely event your employment is terminated for cause or should you voluntarily resign during your first year of employment, you will be required to repay the Bonus amount that has been paid to you as of your termination date.

Stock Options
Subject to receipt of necessary approvals following the date of the commencement of your employment with the Company, Radius will grant to you 60,000 stock options (the “Options”) for the purchase of common stock of Radius, at a price equal to the closing price value of Radius’ stock on the date the Options are approved. The Options will vest as to 25% of the underlying shares on the first anniversary of the grant date and in equal monthly installments over the following thirty-six (36) months. The Options shall be subject to all terms, vesting schedules, limitations, restrictions and termination provisions set forth in the applicable Radius stock option plan and in a separate option agreement that shall be executed by you and Radius to evidence the grant of the Options.

Relocation
For the first year of employment you will receive a monthly stipend of $3,500.00 to cover temporary living expenses at our Wayne location.  At the conclusion of your first year of employment we will agree upon a reasonable and customary amount for your future relocation expenses. 

Benefits
You also will be eligible to participate in a generous employee benefits program, an overview of which is enclosed, provided you are eligible under, and subject to all provisions of, the plan documents governing the program. Some benefit plans will require you to make elections and choose levels of coverage to meet your personal needs.  Effective the first of the month following your date of hire, you will be eligible to begin participation in the Company’s benefits plans including health and dental insurance, life insurance, short and long term disability, as well as Flexible Spending Accounts, and the Company’s 401(k) Plan.

You are eligible to accrue 20 days of paid vacation time per year, which shall accrue on a pro-rated monthly basis and may be used in accordance with Radius’ regular policies. Your vacation days will be pro-rated during the first year of employment.

All of the Company's employee plans, to include all compensation and benefit programs, are subject to change at any time, at the sole discretion of the Company, and the plan provisions in effect from time to time will govern all awards and benefits provided.

Severance
On or prior to your commencing employment, you and the Company will enter into the Company’s current form of Executive Severance Agreement (the “Severance Agreement”), which agreement will govern the payments and benefits you may receive upon a termination of your employment with the Company. Except as otherwise provided in the Severance Agreement, the Company's obligations to you under this Agreement will cease upon your termination of employment for any reason.

Confidentiality And Post-Employment Obligations
As a condition of employment, you hereby agree to execute and abide by the Company’s current form of Confidentiality and Non-Competition Agreement (“Confidentiality Agreement”), which may be amended by the parties from time to time without regard to this Agreement. The Confidentiality Agreement contains provisions that are intended by the parties to survive and do survive termination of this Agreement. Radius expects that you will honor your contractual and/or common-law obligations  not to disclose any confidential, proprietary or trade secret information (such as formulas, marketing or development plans, or confidential client information) you acquired while employed by your current or former employers. Furthermore, to the extent you have post-employment contractual obligations to another employer, by signing this letter you certify to Radius that you will be able to fully perform the duties and responsibilities of your position with Radius without violating any obligations to any former employer.

Term and Termination
This Agreement shall commence on your first day of your employment with the Company. This Agreement is not intended to be, and should not be construed as, a contract of employment for any specific period of time. Employment at Radius is at-will, which means that either you or Radius may terminate your employment at any time. Radius also reserves the right to change the terms and conditions of your employment, including the provisions of compensation and benefits programs, at any time.

Successors
This Agreement is personal to you and without the prior written consent of the Company you shall not assign your rights or obligations under this Agreement, otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by your legal representatives. This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.

Applicable Law
This Agreement has been made under and shall be construed and enforced in accordance with the laws of the Commonwealth of Massachusetts, disregarding any choice of law rules that would result in the application of the laws of another jurisdiction.

Notice
Any notice, statement or demand required to be given under this Agreement shall be in writing and shall be sent by hand delivery against receipt, certified mail, return receipt requested or by a nationally recognized overnight carrier to the address of the parties first listed above or such other address as either party subsequently provides to the other in accordance with the provisions of this paragraph.

Waiver
The failure of either party to insist upon strict performance of any of the terms or provisions of this Agreement or to exercise any option, right or remedy contained in this Agreement, shall not be construed as a waiver or as a relinquishment for the future of such term, provision, option, right or remedy, but the same shall continue and remain in full force and effect. No waiver by either party of any term or provision of this Agreement shall be deemed to have been made unless expressed in writing and signed by such party.

Entire Agreement
If you accept this offer, this Agreement, the Confidentiality Agreement and the Severance Agreement shall constitute the complete agreement between you and the Company with respect to the terms and conditions of your employment. Any prior or contemporaneous representations (whether oral or written) not contained in this Agreement, the Confidentiality Agreement or the Severance Agreement or contrary to those contained in this Agreement, the Confidentiality Agreement or the Severance Agreement that may have been made to you are expressly cancelled and superseded by this offer. Except as otherwise specified herein, the terms and conditions of your employment may not be changed, except in another written agreement, signed by you and an authorized representative of the Company.

Joseph, we are thrilled to have you accept as the Company’s Senior Vice President, Sales and Marketing and look forward to you joining Radius. If this Agreement correctly sets forth the terms under which you will be employed by Radius, please countersign this letter in the space provided below. Please return your countersigned offer letter to Deb Kauffman by e-mail by 5:00 pm (EDT) on November 11, 2017. After that date, this offer of employment will expire.

Best regards,

/s/ Jesper Høiland
                        
Jesper Høiland
President and Chief Executive Officer

This letter supersedes any and all prior understandings, whether written or oral, relating to the terms of your employment.  By signing below, you agree that you are not relying on any representations other than as set out above, and that you accept employment with Radius on the terms set forth in this letter.

Signature: /s/ Joseph Kelly        Date: November 10, 2017    

cc:  D. Kauffman

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}]]